148 related articles for article (PubMed ID: 38314885)
21. Combinations of laxatives and green banana biomass on the treatment of functional constipation in children and adolescents: a randomized study.
Cassettari VMG; Machado NC; Lourenção PLTA; Carvalho MA; Ortolan EVP
J Pediatr (Rio J); 2019; 95(1):27-33. PubMed ID: 29309737
[TBL] [Abstract][Full Text] [Related]
22. Evaluation and Comparison of Daiokanzoto and Lubiprostone for Constipation: A Retrospective Cohort Study.
Yoshida A; Hirose T; Kuroda A; Mitsuoka M; Shinoda Y; Mori K; Kawachi Y; Tanaka K; Takeda A; Sugiyama T; Yoshimura T
Biol Pharm Bull; 2019; 42(5):680-684. PubMed ID: 31061310
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of lubiprostone for the treatment of chronic idiopathic constipation: A phase 3, randomized, placebo-controlled study.
Coss-Adame E; Remes-Troche JM; Flores Rendón R; Tamayo de la Cuesta JL; Valdovinos Díaz MA
Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):70-79. PubMed ID: 37225537
[TBL] [Abstract][Full Text] [Related]
24. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
[TBL] [Abstract][Full Text] [Related]
25. Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.
Corsetti M; Landes S; Lange R
Neurogastroenterol Motil; 2021 Oct; 33(10):e14123. PubMed ID: 33751780
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation.
Paré P; Fedorak RN
Can J Gastroenterol Hepatol; 2014 Nov; 28(10):549-57. PubMed ID: 25390617
[TBL] [Abstract][Full Text] [Related]
27. [A Randomized, Double-blind, Active-controlled Exploratory Clinical Trial for the Evaluation of the Efficacy and Safety of Goodmorning S Granule
Ju M; Kim N; Shin CM; Park YS; Yoon H; Choi Y; Lee DH
Korean J Gastroenterol; 2022 Jul; 80(1):17-27. PubMed ID: 35879059
[TBL] [Abstract][Full Text] [Related]
28. Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial.
Hussain SZ; Labrum B; Mareya S; Stripling S; Clifford R
J Pediatr Gastroenterol Nutr; 2021 Nov; 73(5):572-578. PubMed ID: 34387619
[TBL] [Abstract][Full Text] [Related]
29. Long-term Use of Bisacodyl in Pediatric Functional Constipation Refractory to Conventional Therapy.
Bonilla S; Nurko S; Rodriguez L
J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):288-291. PubMed ID: 32459741
[TBL] [Abstract][Full Text] [Related]
30. Lubiprostone: chloride channel activator for chronic constipation.
Rivkin A; Chagan L
Clin Ther; 2006 Dec; 28(12):2008-21. PubMed ID: 17296458
[TBL] [Abstract][Full Text] [Related]
31. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
Jamal MM; Adams AB; Jansen JP; Webster LR
Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
[TBL] [Abstract][Full Text] [Related]
33. Aetiological spectrum, clinical differentiation and efficacy of polyethylene glycol over lactulose in children with constipation: Experience of 316 cases.
Poddar U; Singh S; Pawaria A; Srivastava A; Yachha SK
J Paediatr Child Health; 2019 Feb; 55(2):162-167. PubMed ID: 29943871
[TBL] [Abstract][Full Text] [Related]
34. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
Owen RT
Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
[TBL] [Abstract][Full Text] [Related]
35. Lubiprostone in constipation: clinical evidence and place in therapy.
Wilson N; Schey R
Ther Adv Chronic Dis; 2015 Mar; 6(2):40-50. PubMed ID: 25729555
[TBL] [Abstract][Full Text] [Related]
36. Effect of polyethylene glycol versus lactulose on abdominal pain in children occult constipation: a randomized controlled study.
Hakimzadeh M; Mottaghi S; Ahmadi M; Javaherizadeh H
Rev Gastroenterol Peru; 2019; 39(4):323-328. PubMed ID: 32097391
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.
Müller-Lissner S
Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):391-401. PubMed ID: 23425050
[TBL] [Abstract][Full Text] [Related]
38. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
39. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
[TBL] [Abstract][Full Text] [Related]
40. Systematic review with meta-analysis: lubiprostone efficacy on the treatment of patients with constipation.
Passos MDCF; Takemoto MLS; Corradino GC; Guedes LS
Arq Gastroenterol; 2020; 57(4):498-506. PubMed ID: 33331483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
